Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 273, Issue 5 36-5, 1997, Pages

  Hettiarachchi, M ^a   Chalkley, S ^a   Furler, S M ^a   Choong, Y S ^b   Heller, M ^b   Cooper, G J S ^b,c   Kraegen, E W ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Euglycemic clamp; Human growth hormone; Liver; Long chain acyl CoA; Muscle; Triglycerides

Indexed keywords

AMYLIN; HUMAN GROWTH HORMONE; INSULIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERINSULINEMIA; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030686409     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.273.5.e859     Document Type: Article

References (14)

1. Aiyar, N., E. Baker, J. Martin, A. Patel, J. M. Stadel, R. N. Willette, and F. C. Barone. Differential calcitonin gene-related peptide (CGRP) and amylin binding sites in nucleus accumbens and lung: potential models for studying CGRP/amylin receptor subtypes. J. Neurochem. 65: 1131-1138, 1995.
2. Bennet, W. M., C. S. Beis, M. A. Ghatei, P. G. Byfield, and S. R. Bloom. Amylin tonally regulates arginine-stimulated insulin secretion in rats. Diabetologia 37: 436-438, 1994.
3. Bhogal, R., D. M. Smith, and S. R. Bloom. Investigation and characterisation of binding sites for islet amyloid polypeptide in rat membranes. Endocrinology 130: 906-913, 1992.
4. Black, J. Nobel Lecture in Physiology or Medicine - 1988. Drugs from emasculated hormones: the principle of syntopic antagonism. In Vitro Cell. Dev. Biol. 25: 311-320, 1989.
5. Carr, T. P., C. J. Andresen, and L. L. Rudel. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin. Biochem. 26: 39-42, 1993.
6. 1 receptors. J. Pharmacol. Exp. Ther. 269: 989-992, 1994.
7. Cooper, G. J. S. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr. Rev. 15: 163-201, 1994.
8. Cooper, G. J. S., B. Leighton, G. D. Dimitriadis, M. Parry-Billings, J. M. Kowalchuk, K. Howland, J. B. Rothbard, A. C. Willis, and K. B. Reid. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc. Natl. Acad. Sci. USA 85: 7763-7766, 1988.
9. Davidson, M. B. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr. Rev. 8: 115, 1987.
10. Deems, R. O., F. Cardinaux, R. W. Deacon, and D. A. Young. Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanism. Biochem. Biophys. Res. Commun. 174: 716- 720, 1991.
11. Gardiner, S. M., A. M. Compton, P. A. Kemp, T. Bennett, C. Bose, R. Foulkes, and B. Hughes. Antagonistic effects of human alpha-calcitonin gene-related peptide (8-37) on regional hemodynamic actions of rat islet amyloid polypeptide in conscious Long-Evans rats. Diabetes 40: 948-951, 1991.
12. Hanabusa, T., K. Kuba, C. Oki, Y. Nakano, K. Okai, T. Sanke, and K. Nanjo. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 15: 89-96, 1992.
13. Handel, E.V. Estimation of glycogen in small amounts of tissue. Anal. Biochem. 11: 256-265, 1965.
14. Hettiarachchi, M., A. Watkinson, A. B. Jenkins, V. Theos, K. K. Y. Ho, and E. W. Kraegen. Growth hormone-induced insulin resistance and its relationship to lipid availability in the rat. Diabetes 45: 415-421, 1996.